Amedeo Smart

Free Medical Literature Service


 

Amedeo

Malaria

  Free Subscription

Articles published in
Lancet
    April 2022
  1. THE LANCET
    Malaria in 2022: a year of opportunity.
    Lancet. 2022;399:1573.
    >> Share

  2. NOOR AM, Alonso PL
    The message on malaria is clear: progress has stalled.
    Lancet. 2022 Apr 21. pii: S0140-6736(22)00732.
    >> Share

    March 2022
  3. MOSHA JF, Kulkarni MA, Lukole E, Matowo NS, et al
    Effectiveness and cost-effectiveness against malaria of three types of dual-active-ingredient long-lasting insecticidal nets (LLINs) compared with pyrethroid-only LLINs in Tanzania: a four-arm, cluster-randomised trial.
    Lancet. 2022;399:1227-1241.
    >> Share

    February 2022
  4. WHITE NJ, Day NPJ, Ashley EA, Smithuis FM, et al
    Have we really failed to roll back malaria?
    Lancet. 2022;399:799-800.
    >> Share

    January 2022
  5. MCCALL C
    Disrupted care in Papua New Guinea: the harms of COVID-19.
    Lancet. 2022;399:226-227.
    >> Share

    December 2021
  6. VAN DER PLUIJM RW, Phyo AP, Lek D, White NJ, et al
    Triple artemisinin-based combination therapies for malaria: proceed with caution - Authors' reply.
    Lancet. 2021;396:1976-1977.
    >> Share

  7. WANG J, Xu C, Wong YK, Ma N, et al
    Triple artemisinin-based combination therapies for malaria: proceed with caution.
    Lancet. 2021;396:1976.
    >> Share

  8. HOSSEINPOOR AR, Bergen N, Kirkby K, Schlotheuber A, et al
    Monitoring inequalities is a key part of the efforts to end AIDS, tuberculosis, and malaria.
    Lancet. 2021 Dec 8. pii: S0140-6736(21)02756.
    >> Share

    October 2021
  9. SAMARASEKERA U
    Cautious optimism for malaria vaccine roll-out.
    Lancet. 2021;398:1394.
    >> Share

  10. THE LANCET
    Malaria vaccine approval: a step change for global health.
    Lancet. 2021;398:1381.
    >> Share

    May 2021
  11. MOORTHY V, Binka F
    R21/Matrix-M: a second malaria vaccine?
    Lancet. 2021 May 5. pii: S0140-6736(21)01065.
    >> Share

  12. DATOO MS, Natama MH, Some A, Traore O, et al
    Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.
    Lancet. 2021 May 5. pii: S0140-6736(21)00943.
    >> Share

    April 2021
  13. LANE R
    Faith Osier: inspirational immunologist.
    Lancet. 2021;397:1533.
    >> Share

    March 2021
  14. THE LANCET
    Myanmar's democracy and health on life support.
    Lancet. 2021;397:1035.
    >> Share

    February 2021
  15. BATH D, Cook J, Govere J, Mathebula P, et al
    Effectiveness and cost-effectiveness of reactive, targeted indoor residual spraying for malaria control in low-transmission settings: a cluster-randomised, non-inferiority trial in South Africa.
    Lancet. 2021;397:816-827.
    >> Share

  16. STERNBERG ED, Cook J, Alou LPA, Assi SB, et al
    Impact and cost-effectiveness of a lethal house lure against malaria transmission in central Cote d'Ivoire: a two-arm, cluster-randomised controlled trial.
    Lancet. 2021;397:805-815.
    >> Share

  17. HSIANG MS, Mumbengegwi D, Chimumbwa J
    Mini-outbreak response for malaria using indoor residual spraying.
    Lancet. 2021;397:771-773.
    >> Share

  18. CHANDA E
    Averting malaria transmission with lethal house lure intervention.
    Lancet. 2021;397:769-771.
    >> Share

    December 2020

  19. Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study.
    Lancet. 2020;396:1829-1840.
    >> Share

  20. ASHLEY EA, Yeka A
    Seasonal malaria chemoprevention: closing the know-do gap.
    Lancet. 2020;396:1778-1779.
    >> Share

    November 2020
  21. MAKONI M
    Violence leads to health emergencies in Mozambique.
    Lancet. 2020;396:1621.
    >> Share

    June 2020
  22. PRICE RN, Taylor WRJ, Thriemer K, White NJ, et al
    Primaquine for Plasmodium vivax malaria treatment - Authors' reply.
    Lancet. 2020;395:1972.
    >> Share

  23. KARUNAJEEWA H, James R
    Primaquine for Plasmodium vivax malaria treatment.
    Lancet. 2020;395:1971-1972.
    >> Share

    April 2020
  24. CHEN I, Dondorp A, Gosling R, Harvard K, et al
    Malaria eradication - Authors' reply.
    Lancet. 2020;395:e73.
    >> Share

  25. ECKL J
    Malaria eradication.
    Lancet. 2020;395:e72.
    >> Share

  26. MOLYNEUX D
    Malaria eradication.
    Lancet. 2020;395:e71.
    >> Share

  27. KENNEDY J, McCoy D
    Malaria eradication.
    Lancet. 2020;395:e70.
    >> Share

  28. WANG J, Xu C, Wong YK, Liao FL, et al
    Malaria eradication.
    Lancet. 2020;395:e69.
    >> Share

  29. MULLER O, Lu G, Jahn A, Razum O, et al
    Malaria eradication.
    Lancet. 2020;395:e68.
    >> Share

  30. ANTIPORTA DA, Rosas-Aguirre A, Chang J, Llanos-Cuentas A, et al
    Malaria eradication.
    Lancet. 2020;395:e67.
    >> Share

  31. HSIANG MS, Ntuku H, Roberts KW, Dufour MK, et al
    Effectiveness of reactive focal mass drug administration and reactive focal vector control to reduce malaria transmission in the low malaria-endemic setting of Namibia: a cluster-randomised controlled, open-label, two-by-two factorial design trial.
    Lancet. 2020;395:1361-1373.
    >> Share

  32. KEATING C
    The history of the RTS,S/AS01 malaria vaccine trial.
    Lancet. 2020;395:1336-1337.
    >> Share

  33. HETZEL MW, Chitnis N
    Reducing malaria transmission with reactive focal interventions.
    Lancet. 2020;395:1317-1319.
    >> Share


  34. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3.
    Lancet. 2020 Apr 23. pii: S0140-6736(20)30608.
    >> Share

  35. SUNDEWALL J, Forsberg BC
    Understanding health spending for SDG 3.
    Lancet. 2020 Apr 23. pii: S0140-6736(20)30963.
    >> Share

  36. STAEDKE SG, Gonahasa S, Dorsey G, Kamya MR, et al
    Effect of long-lasting insecticidal nets with and without piperonyl butoxide on malaria indicators in Uganda (LLINEUP): a pragmatic, cluster-randomised trial embedded in a national LLIN distribution campaign.
    Lancet. 2020;395:1292-1303.
    >> Share

  37. BAJUNIRWE F
    Pyrethroid resistance in sub-Saharan Africa.
    Lancet. 2020;395:1236-1237.
    >> Share

  38. KILLEEN GF
    Control of malaria vectors and management of insecticide resistance through universal coverage with next-generation insecticide-treated nets.
    Lancet. 2020 Apr 15. pii: S0140-6736(20)30745.
    >> Share

    March 2020
  39. WANG J, Xu C, Wong YK, He Y, et al
    Preparedness is essential for malaria-endemic regions during the COVID-19 pandemic.
    Lancet. 2020 Mar 16. pii: S0140-6736(20)30561.
    >> Share

  40. VAN DER PLUIJM RW, Tripura R, Hoglund RM, Pyae Phyo A, et al
    Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
    Lancet. 2020 Mar 11. pii: S0140-6736(20)30552.
    >> Share

  41. ROSENTHAL PJ
    Are three drugs for malaria better than two?
    Lancet. 2020 Mar 11. pii: S0140-6736(20)30560.
    >> Share

  42. MCGREADY R, Nosten F, Barnes KI, Mokuolu O, et al
    Why is WHO failing women with falciparum malaria in the first trimester of pregnancy?
    Lancet. 2020;395:779.
    >> Share

    January 2020
  43. FOWKES FJI, Davidson E, Moore KA, McGready R, et al
    The invisible burden of malaria-attributable stillbirths.
    Lancet. 2020;395:268.
    >> Share

  44. GETHING P, Hay S, Weiss D
    The invisible burden of malaria-attributable stillbirths - Authors' reply.
    Lancet. 2020;395:268-269.
    >> Share

    October 2019
  45. TCHIOMBIANO S, Delfraissy JF, Dabis F
    The Global Fund's Sixth Replenishment Conference: a challenge for France, a challenge for global health.
    Lancet. 2019;394:1214-1215.
    >> Share

    September 2019
  46. FOY BD, Rao S, Parikh S, Slater HC, et al
    Analysis of the RIMDAMAL trial - Authors' reply.
    Lancet. 2019;394:1006-1007.
    >> Share

  47. COLEBUNDERS R, Kugler M, Fodjo JNS
    Analysis of the RIMDAMAL trial.
    Lancet. 2019;394:1006.
    >> Share

  48. BRADLEY J, Moulton LH, Hayes R
    Analysis of the RIMDAMAL trial.
    Lancet. 2019;394:1005-1006.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016